These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10829062)

  • 1. The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.
    Shishido T; Akagi T; Ouchi T; Georgescu MM; Langdon WY; Hanafusa H
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6439-44. PubMed ID: 10829062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE; Thien CB; Langdon WY
    Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
    Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
    Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT; de Jong R; Park RK; Liu Y; Heisterkamp N; Groffen J; Durden DL
    J Immunol; 1998 Nov; 161(10):5555-63. PubMed ID: 9820532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
    Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
    Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.
    Grossmann AH; Kolibaba KS; Willis SG; Corbin AS; Langdon WS; Deininger MW; Druker BJ
    FEBS Lett; 2004 Nov; 577(3):555-62. PubMed ID: 15556646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.
    Alexandropoulos K; Baltimore D
    Genes Dev; 1996 Jun; 10(11):1341-55. PubMed ID: 8647432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase.
    Hunter S; Koch BL; Anderson SM
    Mol Endocrinol; 1997 Aug; 11(9):1213-22. PubMed ID: 9259313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase.
    Howlett CJ; Bisson SA; Resek ME; Tigley AW; Robbins SM
    Biochem Biophys Res Commun; 1999 Apr; 257(1):129-38. PubMed ID: 10092522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2.
    Husson H; Mograbi B; Schmid-Antomarchi H; Fischer S; Rossi B
    Oncogene; 1997 May; 14(19):2331-8. PubMed ID: 9178909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction.
    Kirsch KH; Georgescu MM; Shishido T; Langdon WY; Birge RB; Hanafusa H
    J Biol Chem; 2001 Feb; 276(7):4957-63. PubMed ID: 11067845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.